Nicolas Piuzzi, MD
Adult Reconstructive Orthopaedic Surgery · Cleveland, OHNPI 1669924858
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,095,553 of the $1,170,103 with a category attached, or 93.6%. Zimmer Biomet accounts for 64.6% of it on its own, with 17 other manufacturers making up the rest. 2025 is the largest year on record at $749,839, more than ten times the $1,628 reported in 2019. Among adult reconstructive orthopaedic surgery clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 524 payments — averaging $2233.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$756K
- Stryker$370K
- Pacira Pharmaceuticals Incorporated$24K
- Ethicon Endo-surgery Inc.$10K
- Regeneron$5K
- Johnson & Johnson$2K
- plus $3K from 12 others
Across 74 payments — averaging $10,037 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Zimmer Biomet$492K
- Canary Medical USA LLC$224K
- Acumed LLC$15K
- Medical Device Business Services, Inc.$12K
What the payments were for
- Consulting fees$1,095,55394%
- Travel & lodging$58,6435%
- Food & beverage$13,2721%
- Education$2,6000%
- Gifts$350%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 94 | $755,792 |
| Stryker | 392 | $370,361 |
| Pacira Pharmaceuticals Incorporated | 18 | $23,861 |
| Ethicon Endo-surgery Inc. | 1 | $10,200 |
| Regeneron | 1 | $5,320 |
| Johnson & Johnson(2 entities) | 4 | $1,912 |
| KCI USA, Inc. | 2 | $975 |
| Pfizer | 1 | $630 |
| Bone Support Inc. | 2 | $209 |
| Davol Inc. | 1 | $148 |
| Think Surgical, Inc. | 1 | $143 |
| Hydrocision, Inc. | 1 | $109 |
| Smith+Nephew | 1 | $101 |
| Convatec Inc. | 1 | $100 |
| Medtronic | 1 | $85 |
| Biocomposites Inc | 1 | $76 |
| Pacira Therapeutics, Inc. | 1 | $45 |
| Theradaptive, Inc. | 1 | $35 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$215,888
- TRIATHLON$78,774
- PRO-DENSE$41,787
- BIO4$26,871
- GMRS$25,440
- INSIGNIA$23,868
- EXPAREL$21,758
- ALLOFIBER$13,843
- RESTORATION$13,650
- PRO-STIM$12,640
- ALLOMATRIX$12,150
- STRATAFIX$12,015
- BIOLOX$11,750
- ALLOGRAFT$10,575
- TRIDENT$10,500
- DERMABOND PRINEO$10,200
- MONOCRYL$10,200
- Iovera$6,974
- AUGMENT INJECTABLE$6,410
- Zilretta$5,148
How this compares
$1,170,103 in reported general payments places this provider in the 90th percentile of 59 adult reconstructive orthopaedic surgery providers in Ohio.
See all adult reconstructive orthopaedic surgery providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 13 | $9 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Cleveland
- Viktor KrebsCleveland$7.5M
- Michael BloomfieldCleveland$321K
- Trevor MurrayCleveland$192K
- James VoosCleveland$166K
- Peter SuraceCleveland$146K
- Kim StearnsCleveland$80K
- John McLaughlinCleveland$79K
- Mark DenzineCleveland$31K
- Michael KolczunCleveland$22K
- Michael ErossyCleveland$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.